KORRO BIO INC. - COMMON STOCK

37.30

24-一月-25 15:45:00

15 分钟延时

股票

-0.66

-1.74%

今日范围

37.25 - 38.91

ISIN

N/A

来源

NASDAQ

Korro to Present at the TD Cowen 44th Annual Health Care Conference

27 2月 2024 07:00:01 条件 Nasdaq GlobeNewswire
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

18 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference

04 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

07 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

<<
<
1
2
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.